MedPath

Efficacy, safety and general effect of intra-articular and intraosseous infiltrations of Platelet Rich Plasma in patients with knee osteoarthritis: Randomized Clinical Trial

Conditions
Knee osteoarthritis
Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
Registration Number
EUCTR2015-004738-90-ES
Lead Sponsor
Arthroscopic Surgery Unit
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Patients of both sexes aged between 40 and 85 years old.
Diagnosed with osteoarthritis predominantly in the medial tibiofemoral compartment through X-ray knee clinical study.
Joint pain than or equal to 2.5 points in VAS.
Radiological severity grades 1, 2, 3, 4 according to the Ahlbäck scale.
Values of Body Mass Index between 20 and 35.
Serological tests negative against syphilis, HIV, HBV and HCV.
Possibility for observation during the monitoring period
Signed informed consent
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 60
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 60

Exclusion Criteria

Gonarthrosis requiring infiltration in both knees
BMI> 35
Mechanical deformity requiring osteotomy.
Previous arthroscopy in the last year.
Intra-articular injection of hyaluronic acid in the last 6 months.
Systemic autoimmune rheumatic disease (connective tissue diseases and systemic necrotizing vasculitis).
Poorly controlled diabetes (glycosylated hemoglobin above 9%)
Blood disorders (thrombopathy, thrombocytopenia, anemia with Hb <9).
It is undergoing immunosuppressive treatments.
Treatment with steroids during the 6 months prior to inclusion in the study.
Patients unable to stop treatment with NSAIDs during the study.
Pregnancy and lactation.
Polyarticular disease diagnosed.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath